RESOLVE Trial Data Signals Dose-Dependent Clinical Improvement
Strong Clinical Efficacy Supports Regulatory Momentum
Q2 FY2026 Performance: U.S. Weakness Drives Revenue Decline
Q1 2026 Earnings Beat Expectations Despite Modest Revenue Growth
Revenue Growth Outpaces Expectations in Q1 2026 Results
Strategic Capital Raise and Balance Sheet Implications
Capital Structure Simplification Through Royalty Buyback
MPLX LP (NYSE:MPLX) Q1 2026 EPS of USD 0.90 missed the consensus by 15%, with revenue of USD 3.04 billion falling short of forecasts, as pipeline volume declines and NGL price headwinds weighed on results despite adjusted EBITDA of USD 1.7 billion and a …
FINRA eliminates the USD 25,000 Pattern Day Trader rule effective June 4, 2026, replacing it with a real-time intraday margin framework under amended Rule 4210. Here is what changes, what does not, and what it means for retail market structure.Key HighlightsFINRA eliminates the Pattern …
Freight Markets Enter Stress Territory